Anjarium Anjarium Anjarium

Anjarium

Non-viral gene therapies

Anjarium Biosciences AG is a cell and gene therapy tools and technology company based in Switzerland and the U.S. Anjarium is capable of designing, manufacturing, and supplying synthetic DNA as well as targeted non-viral vectors for the delivery of a diverse set of payloads.

Life Sciences

Visit website

Investment  details

Entry

2021

Staff

Location

Switzerland

Exit

2024

As the limitations of conventional viral-vector based gene therapies to deliver optimal patient outcomes become increasingly evident, a fully non-viral approach represents an exciting new therapeutic opportunity.

Joël De Beer

Founder & CSO

Partnership Gimv Partnership Gimv Partnership Gimv

Partnership Gimv

Anjarium pursues a highly innovative approach that combines cutting-edge science and expertise in genetic medicine with synthetic biology. Anjarium's unique platform, which is based on a proprietary DNA-based production technology, enables the targeted development and production of gene therapies for a wide range of diseases.